[New developments in tocolysis].
Lechner
W
W
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D046508:Culture Techniques; D005260:Female; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011247:Pregnancy; D045167:Progesterone Congeners / Q000494:pharmacology; D015149:Tocolytic Agents / Q000494:pharmacology*; D014590:Uterine Contraction / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D010726:Phosphodiesterase Inhibitors; D045167:Progesterone Congeners; D015149:Tocolytic Agents
Neue Entwicklung in der Tokolyse.